Health Protection Agency
- Tel: +44 (0) 1980 612 100
- Contact this Company »
- Visit Web Site »
The Health Protection Agency (HPA) is a national organisation which is dedicated to protecting people’s health and reducing the impact of infectious diseases, chemical hazards, poisons and radiation hazards.
The Business Division of the HPA is based at Porton Down, formerly CAMR. HPA Porton Down's core business areas are research and development of vaccines against infectious diseases, process development and GMP manufacture of biologics derived from microbial fermentation - particularly those requiring containment or focused on the bio-defence market.
In addition, a wide range of support services are offered from bio safety, through GLP immunoassay testing to in-vivo studies and the supply of cell cultures.
Health Protection Agency
Business Division
Porton Down
Salisbury
Wiltshire
SP4 0JG
Tel: +44 (0) 1980 612 100
Fax: +44 (0) 1980 612 241
Website: www.hpa.org.uk/business
Health Protection Agency News
- OPi launches Erwinase® in the UK through its newly formed UK subsidiary »
Dr Phil Luton
Erwinase® (crisantaspase), the L-asparaginase derived from Erwinia chrysanthemi, approved and available in UK for the treatment of acute lymphoblastic leukaemia. - Syntaxin Launched in Spin out of Medicines Discovery Programme from UK Health Protection Agency »
Dr Phil Luton
Syntaxin Ltd (Syntaxin), a newly formed biopharmaceutical company focussing on the discovery and development of new medicines for the treatment of neurological, respiratory and metabolic diseases, was today launched as the first spin-out from the UK Health Protection Agency (HPA).
Contract Research and Services
- About Our Services »
Dr Phil Luton
The Agency's microbiological research and testing facilities, backed by 50 years of experience, are internationally recognised, particularly for our expertise in working safely with organisms that require biological containment.
GMP Manufacture
- About Our Services »
Dr Phil Luton
Custom Manufacturing Services: Taking a concept from the bench through to material for clinical trial is challenging.
Partnership
- About Our Services »
Dr Phil Luton
The Agency has a proven track record of generating novel ideas, and an active patenting policy leading to new products and platform technologies.
Immunoassay
- About Our Services »
Dr Phil Luton
The development of effective new vaccines is dependent upon the body being able to generate immune responses to the components of the vaccine that will confer protection against the infectious agents.
Culture Collections
- About Our Services »
Dr Phil Luton
The Health Protection Agency provides national and international reference collections which are sources of micro-organisms of medical importance, together with human and animal cell cultures.
Biopharmaceutical Products
- About Our Services »
Dr Phil Luton
The HPA is the sole manufacturer of the UK's licensed anthrax vaccine. The vaccine is manufactured for and on behalf of the UK Government.
Biotechnology
- HPA Achieves Major Success in Obtaining US Biodefence Funding »
Dr Phil Luton
Direct Government Funding
Health Protection Agency News
- Opi and The UK Health Protection Agency enter into a World-Wide Licensing Agreement on Erwinase® »
Dr Phil Luton
OPi strengthens its onco-haematology portfolio by being granted exclusive worldwide commercialisation rights for Erwinase® (crisantaspase).
Filling and Freeze-drying Facilities
- Upgrade to Filling and Freeze-drying Facility. »
Dr Phil Luton
The Health Protection Agency is undertaking an upgrade and refurbishment of its GMP filling and freeze-drying unit at its Centre at Porton Down at a cost of over £2 million.
Health Protection Agency News
- TSO3 Ozone Sterilizer to be tested by British Government for ability to deactivate prions »
Dr Phil Luton
Québec City, April 14, 2005 - The Health Protection Agency (HPA) has recently been awarded a grant of £327k (approximately $710k CAN) by the UK Department of Health (DH) to study the effectiveness of the TSO3 Ozone Sterilizer for deactivation of prions.
Meningococcal Disease Vaccine
- A New Vaccine to Combat All Forms of Meningococcal Disease »
Fighting disease in developed and developing countries
Meningococcal Pentavalent Vaccines
- Meningitis Vaccine Collaboration »
Dr Phil Luton
Development of a Pan Meningococcal Vaccine for the World.
